未登录 A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies Juric, Dejan; Anderson, Daniel; Dowlati, Afshin; Rodon, Jordi; Lugowska, Iwona; Mandziuk, Slawomir; Song, Yuqin; Woei-A-Jin, Feng Jung Sherida H.; Andre, Marc; Tybor, Joanna Gora; Hernandez-Rivas, Jose-Angel; Kurzrock, Razelle; Lopez-Guillermo, Armando; Schroder, David; Stec, Rafal; Berger, Allison; Chao, Bo; Chudnovsky, Aleksander; Gibbs, John P.; Long, Tao; Stroopinsky, Dina; Dong, Qi; Olszanski, Anthony J. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
A phase I, first-in-human trial of KO-947, an ERK1/2 inhibitor, in patients with advanced solid tumors ERK1/2抑制剂KO-947在晚期实体瘤患者中的I期首次人体试验 Schram, A. M.; Boni, V.; Adjei, A. A.; Olszanski, A. J.; Vieito, M.; Francis, J. H.; Kurman, M.; Ahsan, J. M.; Tomkinson, B.; Garralda, E. 分享 收藏
分享 收藏
分享 收藏
Management of Immunotherapy-Related Toxicities, Version 2.2024 Featured Updates to the NCCN Guidelines 免疫治疗相关毒性的管理，2.2024版以NCCN指南的更新为特色 Thompson, John A.; Schneider, Bryan J.; Brahmer, Julie; Abu Zaid, Mohammad; Achufusi, Amaka; Armand, Philippe; Berkenstock, Meghan K.; Bermas, Bonnie; Braaten, Tawnie; Budde, Lihua E.; Chokshi, Saurin; Crees, Zachary D.; Davies, Marianne; Deng, Changchun; Gesthalter, Yaron; Jain, Michael; Jain, Prantesh; Jallouk, Andrew; Kaffenberger, Benjamin H.; Khalil, Maya; Lechner, Melissa G.; Li, Tianhong; Marr, Alissa; Mcgettigan, Suzanne; Mcpherson, Jordan; Medina, Theresa; Mohindra, Nisha A.; Olszanski, Anthony J.; Oluwole, Olalekan; Patel, Sandip P.; Prosek, Jason; Reddy, Sunil; Reid, Pankti; Ryan, John; Ryder, Mabel; Salman, Huda; Santomasso, Bianca; Shofer, Scott; Sosman, Jeffrey A.; Wang, Yinghong; Zaha, Vlad G.; Zucker, Stephen; Lyons, Megan; Awotiwon, Ajibola; Hang, Lisa 分享 收藏
Dazostinag (TAK-676) alone and in combination with pembrolizumab (pembro) in patients (pts) with advanced/ metastatic solid tumors: Data from phase I dose escalation Dazostinag (TAK-676) 单药及联合 pembrolizumab (pembro) 治疗 advanced/metastatic solid tumors 患者(pts)的疗效：来自 phase I dose escalation 研究的数据 Luke, J. J.; Gao, X.; Olszanski, A. J.; Sanborn, R. E.; Falchook, G. S.; Patel, S.; Bedard, P. L.; Orr, D.; Gibbs, J. P.; Li, C.; Huang, Y-C.; Gregory, R.; Ramesh, R.; Xu, R.; Wu, B.; Ding, K.; Raizer, J.; Lorusso, P. 分享 收藏
Phase I dose escalation study of HFB200603, a best-in-class BTLA antagonist monoclonal antibody (mAb), in monotherapy and in combination with the anti-PD-1 mAb tislelizumab (TIS) in adult patients (pts) with advanced solid tumors HFB200603的I期剂量递增研究，HFB200603是一种同类最佳BTLA拮抗剂单克隆抗体（mAb），用于单药治疗以及与抗PD-1单克隆抗体tislelizumab（TIS）联合治疗成人晚期实体瘤患者（pts）。 De Miguel, M.; Landa Magdalena, A.; Moreno Garcia, V.; Gambardella, V.; Menis, J.; Daniele, G.; El-Khoueiry, A. B.; Spira, A. I.; Gravina, A.; Olszanski, A. J.; Rapaic, O.; Li, J.; Poullain, H.; Margall, G.; Wong, G.; Hedrich, W.; Pollard, J. Russella; Gan, J.; Shi, X.; Andtbacka, R. H. I. 分享 收藏
Melanoma: Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines Swetter, Susan M.; Johnson, Douglas; Albertini, Mark R.; Barker, Christopher A.; Bateni, Sarah; Baumgartner, Joel; Bhatia, Shailender; Bichakjian, Christopher; Boland, Genevieve; Chandra, Sunandana; Chmielowski, Bartosz; Dimaio, Dominick; Dronca, Roxana; Fields, Ryan C.; Fleming, Martin D.; Galan, Anjela; Guild, Samantha; Hyngstrom, John; Karakousis, Giorgos; Kendra, Kari; Kiuru, Maija; Lange, Julie R.; Lanning, Ryan; Logan, Theodore; Olson, Daniel; Olszanski, Anthony J.; Ott, Patrick A.; Ross, Merrick I.; Rothermel, Luke; Salama, April K.; Sharma, Rohit; Skitzki, Joseph; Smith, Emily; Tsai, Katy; Wuthrick, Evan; Xing, Yan; McMillian, Nicole; Espinosa, Sara 分享 收藏
Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies Restifo, Diana; McDermott, Joseph R.; Cvetkovic, Dusica; Dos Santos, Troy; Ogier, Charline; Surumbayeva, Aizhan; Handorf, Elizabeth A.; Schimke, Caleb; Ma, Charlie; Cai, Kathy Q.; Olszanski, Anthony J.; Kathad, Umesh; Bhatia, Kishor; Sharma, Panna; Kulkarni, Aditya; Astsaturov, Igor 分享 收藏
TAK-500 as a single agent and in combination with pembrolizumab in patients (pts) with advanced solid tumors: Rationale and design of a phase I/II study Singh, H.; Diamond, J. R.; Henry, J. T.; Olszanski, A. J.; Rasco, D.; Patel, S. P.; Gregory, R.; Appleman, V. A.; Gibbs, J. P.; Zhang, W.; Wang, C. I.; Parent, A. A.; Chung, V. 分享 收藏
SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma Kottschade, Lisa A.; Pond, Gregory Russell; Olszanski, Anthony J.; Zakharia, Yousef; Domingo-Musibay, Evidio; Hauke, Ralph J.; Curti, Brendan D.; Schober, Sarah; Milhem, Mohammed M.; Block, Matthew Stephen; Hieken, Tina; McWilliams, Robert R. 分享 收藏
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer (vol 128, pg 30, 2023) Curigliano, Giuseppe; Shapiro, Geoffrey I. I.; Kristeleit, Rebecca S. S.; Abdul Razak, Albiruni R. R.; Leong, Stephen; Alsina, Maria; Giordano, Antonio; Gelmon, Karen A. A.; Stringer-Reasor, Erica; Vaishampayan, Ulka N. N.; Middleton, Mark; Olszanski, Anthony J. J.; Rugo, Hope S. S.; Kern, Kenneth A. A.; Pathan, Nuzhat; Perea, Rachelle; Pierce, Kristen J. J.; Mutka, Sarah C. C.; Wainberg, Zev A. A. 分享 收藏
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial 自体T细胞治疗hla-a * 02患者的MAGE-A4实体癌: 1期试验 Hong, David S.; Van Tine, Brian A.; Biswas, Swethajit; McAlpine, Cheryl; Johnson, Melissa L.; Olszanski, Anthony J.; Clarke, Jeffrey M.; Araujo, Dejka; Blumenschein, George R.; Kebriaei, Partow; Lin, Quan; Tipping, Alex J.; Sanderson, Joseph P.; Wang, Ruoxi; Trivedi, Trupti; Annareddy, Thejo; Bai, Jane; Rafail, Stavros; Sun, Amy; Fernandes, Lilliam; Navenot, Jean-Marc; Bushman, Frederic D.; Everett, John K.; Karadeniz, Derin; Broad, Robyn; Isabelle, Martin; Naidoo, Revashnee; Bath, Natalie; Betts, Gareth; Wolchinsky, Zohar; Batrakou, Dzmitry G.; Van Winkle, Erin; Elefant, Erica; Ghobadi, Armin; Cashen, Amanda; Grand'Maison, Anne; McCarthy, Philip; Fracasso, Paula M.; Norry, Elliot; Williams, Dennis; Druta, Mihaela; Liebner, David A.; Odunsi, Kunle; Butler, Marcus O. 分享 收藏
A PHASE 1/2 STUDY OF REGN7075 (EGFRXCD28 COSTIMULATORY BISPECIFIC ANTIBODY) IN COMBINATION WITH CEMIPLIMAB (ANTI-PD-1) IN PATIENTS WITH ADVANCED SOLID TUMORS: INITIAL DOSE-ESCALATION RESULTS Johnson, Melissa; Lakhani, Nehal; Girda, Eugenia; Olszanski, Anthony; Fong, Lawrence; Han, Hyunsil; Casey, Kerry; Li, Siyu; Visich, Jennifer; Skokos, Dmitris; Seebach, Frank; Lowy, Israel; Fury, Matthew; Mathias, Melissa; Segal, Neil 分享 收藏
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer Curigliano, Giuseppe; Shapiro, Geoffrey, I; Kristeleit, Rebecca S.; Razak, Albiruni R. Abdul; Leong, Stephen; Alsina, Maria; Giordano, Antonio; Gelmon, Karen A.; Stringer-Reasor, Erica; Vaishampayan, Ulka N.; Middleton, Mark; Olszanski, Anthony J.; Rugo, Hope S.; Kern, Kenneth A.; Pathan, Nuzhat; Perea, Rachelle; Pierce, Kristen J.; Mutka, Sarah C.; Wainberg, Zev A. 分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
.png){kind=icon}
分享.png){kind=icon}
收藏